Anavex Life Sciences Corp (AVXL)

[rx7171]

My concern is we won’t get any 3-71 data until there is a substantial time after the trial conclusion to look for a delayed negative signal and durability of response.

This has not been mentioned by the company but we have been blindsided by unexpected delays in the past, such as two years waiting for the peer reviewed article on the AD 2b/3 trial.
That actually may have been intentional to give time for the OLE data to come available to supplement the MAA submittal.